Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Problem With Somaxon's Silenor
Seeking Alpha
Thursday, June 24, 2010 - 10:22am
tags:
Somaxon, Silenor, insomnia
Mylan's Revenge: New Suit Threatens to Double Patent Defense Costs for Big Pharma
BNET Pharma
Thursday, June 24, 2010 - 10:17am
tags:
Mylan, patents, AstraZeneca, Nexium, Prilosec
Pfizer cancels trial of Geodon in bipolar kids
Fierce Pharma
Thursday, June 24, 2010 - 10:12am
tags:
bipolar disorder, Pfizer, Geodon, clinical trials
Drug Pipeline Pulse Check: Roche’s Stumble Boosts Amylin
Seeking Alpha
Thursday, June 24, 2010 - 10:11am
tags:
Roche, Amylin, diabetes, taspoglutide
Savient Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Thursday, June 24, 2010 - 10:09am
tags:
Savient
The Lowdown On Low Testosterone And AndroGel
Pharmalot
Thursday, June 24, 2010 - 10:08am
tags:
testosterone, Androgel, Abbott Laboratories, Solvay
FDA approves Merck asthma treatment
Marketwatch
Thursday, June 24, 2010 - 9:50am
tags:
FDA, Merck, asthma, Dulera
Merck partners with South African drugmaker
Yahoo/AP
Thursday, June 24, 2010 - 9:48am
tags:
Merck, partnerships, South Africa, Adcock Ingram
Former Schering CEO to Be Interrogated on Allegedly Concealed Drug Trial Results
BNET Pharma
Thursday, June 24, 2010 - 9:03am
tags:
Fred Hassan, Schering Plough, Merck, Vytorin
What Investors Think About SuperGen
Motley Fool
Thursday, June 24, 2010 - 9:02am
tags:
investors, Supergen
Pfizer halts studies on osteoarthritis drug
Yahoo/AP
Thursday, June 24, 2010 - 8:42am
tags:
Pfizer, osteoarthritis, tanezumab
Sanofi-Aventis Is `on Track' to Meet Diabetes Sales Targets, Chancel Says
Bloomberg
Thursday, June 24, 2010 - 8:41am
tags:
Sanofi, diabetes, Lantus, Victoza, Novo Nordisk
Drugmakers Finally Recognize the Next Big Opportunity
Motley Fool
Thursday, June 24, 2010 - 8:38am
tags:
BioSante, Merck, GSK, Abbott Laboratories, Neurocrine, Teva Pharmaceuticals, women
Targacept, AstraZeneca begin Phase 3 trial of antidepressant
Bizjournals.com
Wednesday, June 23, 2010 - 11:01am
tags:
Targacept, AstraZeneca, clinical trials, antidepressants
Cubist Pharmaceuticals vs. the Hatch-Waxman Act
Seeking Alpha
Wednesday, June 23, 2010 - 10:59am
tags:
Cubist Pharmaceuticals, Cubicin
Sucampo Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Wednesday, June 23, 2010 - 10:58am
tags:
Sucampo
Buy Vivus Bullish Options Before Review of Obesity Drug, JPMorgan Advises
Bloomberg
Wednesday, June 23, 2010 - 10:57am
tags:
Vivus, obesity
Biotech Stocks Losing Strength
Minyanville
Wednesday, June 23, 2010 - 10:56am
tags:
biotech, Amgen, Gilead Sciences, Biogen Idec, Merck, Eli Lilly, Pfizer, GSK
Genentech says Lucentis gets new FDA approval
Yahoo/AP
Wednesday, June 23, 2010 - 9:14am
tags:
FDA, Genentech, Lucentis, macular edema
Aetna Confirms It Will Cover Provenge
Minyanville
Wednesday, June 23, 2010 - 9:13am
tags:
Aetna, Provenge, prostate cancer, Dendreon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.